Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

Withdrawn before enrolling · Phase 4

Conditions studied: Benign Vascular Periocular Lesions

In brief

The purpose of this research is to find out if the use of topical timolol 0.5% solution applied twice daily will help to shrink rosacea lesions around the eye.

Key facts

Study ID

NCT01250457

Run by

Loyola University

People needed

0

Starts

2010-06-01

Expected to finish

2012-07-01

Last updated by the study team

2012-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Presence of a benign vascular periocular lesion

You may not qualify if…

• Allergy to timolol or beta-blocker class of drugs
• Lesion characteristics concerning for atypia or malignancy including madarosis, ulceration, and recurrence after previous surgery.
• Intraocular Pressure less than 10 mm Hg

Where it is running

• Loyola University Medical Center — Maywood, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.